AMBS News 08/10/2014 00:27:11 $AMBS If i were you
Post# of 64074
Posted On: 08/10/2014 1:27:18 AM
AMBS News 08/10/2014 00:27:11 $AMBS
If i were you Joboggi, I would agree..... fast money. I will be the third party to hold your 1000 and sol's 1000 with me...
and in sep 1st will be 2700 because i will invest in some AMBS while am at it.
INVEST WHERE THE MIRACLE IS
lol, if they do a RS before Labor Day then the pps is automatically above .15 cents. If you are serious then you would not be whining about this.
Let me know before either the open on Monday or before Gerald's blog whichever comes first. We can send the money to an agreed upon third party to hold until either it closes above .15 or Labor Day.
The share price would have to go up almost 37% from Friday's close for me to even have a chance of winning.
You'd practically be stealing my money.
p.s. None of this crap about a split adjusted basis. Either take the bet as proposed or STFU.
I will think about it. It sounds like a good deal to me. Labor day is Sept 1st. It is Aug 9th. The pps is 11 cents and about to go down. It would have to be on a split adjusted basis, although, I do not think they can do a RS before that meeting.
I will think about it.
Quote:
"wonder how much money runners got for AMBS"
they'll be getting 3 hots & a cot soon enough:
I know its difficult - but stay up to date and informed - Bro.
*****************************************************************************************************************************************************
http://www.sec.gov/News/PressRelease/Detail/P...-FQHGP43Ng
SEC Charges 4 Promoters with Manipulating Marijuana-Related Stocks and Other Microcap Companies
The SEC’s complaint filed in federal court in Tacoma, Wash., charges the following individuals:
Mikhail Galas, a stock promoter who lives in Vancouver, Wash.
Alexander Hawatmeh, a member of Worthmore Investments LLC, which owns a stock promotion website called stockhaven.com. He formerly lived in Vancouver and currently resides in Lincoln City, Oregon.
Christopher Mrowca, a stock promoter who operates Money Runners Group LLC, which has an affiliated stock promotion website called MoneyRunnersGroup.com. He lives in Bradenton, Fla.
Tovy Pustovit, who owns a stock promotion website called Explosive Alerts. He also lives in Vancouver.
where is it written the ambs is increasing A/S? Plz advise.
Even so, I have no problem. So many people here diffuse info with no facts just to substantiate sell off. Any opportunity to get cheaper share price from management is welcome by me, not from naysayers or people with veiled agenda.. Please adivse..In GC and AMBS team I trust
I'll bet you $1,000 that the share prices closes above .15 between now and Labor Day.
Take the bet. I can use the extra $1,000.
Interesting week ahead.
p.s. I don't expect you to make the bet. I know I wouldn't.
Note: I'll make the same bet with anyone else before either the open on Monday or Gerald's next blog which ever comes first.
New shares mean it is almost 100% certain $AMBS will 1) spin-out Diagnostics division, 2) #LymPro partner is a whale, 3) NASDAQ in 4-6 month
yo Iam - you don't even know what the "proposed" AS increase is for....
do you even own stock here...
there was provision in the filing for a disproportional reverse split
comprende ?
That is true.
have to look it up again, on the way out the door right now. will check when I get back.
wonder how much money runners got for AMBS
I missed the MJFF reference, do you have a link for that? Ok, that was the Nov 9 2012 "correction." of the MANF pd data. ok, got it.
yeah but they are not going to sell them, according to the financials they had $875 in the bank at the end of last year and according to a poster here that claims AMBS has never been promoted it will have A 500 MILLION DOLLAR A YEAR OPPORTUNITY at the end of this year. so there ya go, proof that they are not going to need the extra billion. maybe I should do some research into how many time the A/S has been raised in the last few years. hummm
Companies release BAD NEWS after the close on Friday to soften the blow, which it usually doesn't if it is really bad like this one. But that is the best time to do it.
But they will never sell all of those shares, JUST LIKE THEY DID NOT SELL MOST OF THE LAST BILLION.
Dr. Commissiong has served as the Chief Scientific Officer and a Director of Amarantus since co-founding the company in 2008. Prior to Amarantus, Dr. Commissiong served as the CSO of Neurotrophics, Inc. and Prescient Neuropharma, Inc. Throughout his distinguished career, Dr. Commissiong has been focused on the discovery of novel neurotrophic factors for the treatment of neurodegenerative diseases as well as understanding the fundamental underlying biology of protoplasmic type-1 astrocytes that secrete neurotrophic factors. He was Chief of the Neural Transplantation Unit, NINDS-NIH, from 1989-94 where his research focused on identifying therapeutic approaches to spinal cord injury. Dr. Commissiong was Head of the Neurotrophic Factors Group, NINDS-NIH, from 1994-97 where he focused on developing technologies to systematically identify novel neurotrophic factors with applications for specific Central Nervous System disorders. He co-founded Prescient Neuropharma in 1999, and discovered MANF in 2003. MANF is currently in preclinical development for the treatment of Parkinson’s disease. The work pioneered by Dr. Commissiong has led to significant advancements in the field of astrocyte-neuron biology. Dr. Commissiong believes that a fundamental understanding of astrocyte-neuron interactions in the Central Nervous System will lead to a new generation of therapies to treat brain-related disorders.
Dr. Commissiong did his Postdoctoral work in the Lab Preclin Pharmac, NIMH-NIH, concentrating on the application of quadrupole mass spectrometry in the analysis of neurotransmitters. He holds a Ph.D. in Neurophysiology from the University of Southampton, an M.Sc. in Biochemical Pharmacology from the University of Southampton, and a B.S. in Biology and Chemistry from the University of the West Indies.
- See more at: http://www.thechairmansblog.com/amarantus-bio...Rb7nz.dpuf
Do I have that right, they are increasing the authorized shares to TWO billion? wow, NOT being listed has its REALLY BIG advantages, you get to print money and not tell anyone when you do it until the end of the quarter.
I firmly believe that AMBS will never need to sell those shares, UNLESS OF COURSE, they want to keep going as a company. oh.
Someone noted that they would have to increase the float if they were going to get the LPC money, because of the tanked pps. I guess that was a correct assertion.
The finance part is not my forte, but I can read, doubling the float when it was just diluted down to undrinkable iced tea, is well, less drinkable.
AMBS the cult stock. How much of the company is owned by institutions? Interesting study in human behavior.
$$$$$$$$$$ AMBS $$$$$$$$$$
company has come a long way from this post in 2012,
If i were you Joboggi, I would agree..... fast money. I will be the third party to hold your 1000 and sol's 1000 with me...
and in sep 1st will be 2700 because i will invest in some AMBS while am at it.
INVEST WHERE THE MIRACLE IS
lol, if they do a RS before Labor Day then the pps is automatically above .15 cents. If you are serious then you would not be whining about this.
Let me know before either the open on Monday or before Gerald's blog whichever comes first. We can send the money to an agreed upon third party to hold until either it closes above .15 or Labor Day.
The share price would have to go up almost 37% from Friday's close for me to even have a chance of winning.
You'd practically be stealing my money.
p.s. None of this crap about a split adjusted basis. Either take the bet as proposed or STFU.
I will think about it. It sounds like a good deal to me. Labor day is Sept 1st. It is Aug 9th. The pps is 11 cents and about to go down. It would have to be on a split adjusted basis, although, I do not think they can do a RS before that meeting.
I will think about it.
Quote:
"wonder how much money runners got for AMBS"
they'll be getting 3 hots & a cot soon enough:
I know its difficult - but stay up to date and informed - Bro.
*****************************************************************************************************************************************************
http://www.sec.gov/News/PressRelease/Detail/P...-FQHGP43Ng
SEC Charges 4 Promoters with Manipulating Marijuana-Related Stocks and Other Microcap Companies
The SEC’s complaint filed in federal court in Tacoma, Wash., charges the following individuals:
Mikhail Galas, a stock promoter who lives in Vancouver, Wash.
Alexander Hawatmeh, a member of Worthmore Investments LLC, which owns a stock promotion website called stockhaven.com. He formerly lived in Vancouver and currently resides in Lincoln City, Oregon.
Christopher Mrowca, a stock promoter who operates Money Runners Group LLC, which has an affiliated stock promotion website called MoneyRunnersGroup.com. He lives in Bradenton, Fla.
Tovy Pustovit, who owns a stock promotion website called Explosive Alerts. He also lives in Vancouver.
where is it written the ambs is increasing A/S? Plz advise.
Even so, I have no problem. So many people here diffuse info with no facts just to substantiate sell off. Any opportunity to get cheaper share price from management is welcome by me, not from naysayers or people with veiled agenda.. Please adivse..In GC and AMBS team I trust
I'll bet you $1,000 that the share prices closes above .15 between now and Labor Day.
Take the bet. I can use the extra $1,000.
Interesting week ahead.
p.s. I don't expect you to make the bet. I know I wouldn't.
Note: I'll make the same bet with anyone else before either the open on Monday or Gerald's next blog which ever comes first.
New shares mean it is almost 100% certain $AMBS will 1) spin-out Diagnostics division, 2) #LymPro partner is a whale, 3) NASDAQ in 4-6 month
yo Iam - you don't even know what the "proposed" AS increase is for....
do you even own stock here...
there was provision in the filing for a disproportional reverse split
comprende ?
That is true.
have to look it up again, on the way out the door right now. will check when I get back.
wonder how much money runners got for AMBS
I missed the MJFF reference, do you have a link for that? Ok, that was the Nov 9 2012 "correction." of the MANF pd data. ok, got it.
yeah but they are not going to sell them, according to the financials they had $875 in the bank at the end of last year and according to a poster here that claims AMBS has never been promoted it will have A 500 MILLION DOLLAR A YEAR OPPORTUNITY at the end of this year. so there ya go, proof that they are not going to need the extra billion. maybe I should do some research into how many time the A/S has been raised in the last few years. hummm
Companies release BAD NEWS after the close on Friday to soften the blow, which it usually doesn't if it is really bad like this one. But that is the best time to do it.
But they will never sell all of those shares, JUST LIKE THEY DID NOT SELL MOST OF THE LAST BILLION.
Dr. Commissiong has served as the Chief Scientific Officer and a Director of Amarantus since co-founding the company in 2008. Prior to Amarantus, Dr. Commissiong served as the CSO of Neurotrophics, Inc. and Prescient Neuropharma, Inc. Throughout his distinguished career, Dr. Commissiong has been focused on the discovery of novel neurotrophic factors for the treatment of neurodegenerative diseases as well as understanding the fundamental underlying biology of protoplasmic type-1 astrocytes that secrete neurotrophic factors. He was Chief of the Neural Transplantation Unit, NINDS-NIH, from 1989-94 where his research focused on identifying therapeutic approaches to spinal cord injury. Dr. Commissiong was Head of the Neurotrophic Factors Group, NINDS-NIH, from 1994-97 where he focused on developing technologies to systematically identify novel neurotrophic factors with applications for specific Central Nervous System disorders. He co-founded Prescient Neuropharma in 1999, and discovered MANF in 2003. MANF is currently in preclinical development for the treatment of Parkinson’s disease. The work pioneered by Dr. Commissiong has led to significant advancements in the field of astrocyte-neuron biology. Dr. Commissiong believes that a fundamental understanding of astrocyte-neuron interactions in the Central Nervous System will lead to a new generation of therapies to treat brain-related disorders.
Dr. Commissiong did his Postdoctoral work in the Lab Preclin Pharmac, NIMH-NIH, concentrating on the application of quadrupole mass spectrometry in the analysis of neurotransmitters. He holds a Ph.D. in Neurophysiology from the University of Southampton, an M.Sc. in Biochemical Pharmacology from the University of Southampton, and a B.S. in Biology and Chemistry from the University of the West Indies.
- See more at: http://www.thechairmansblog.com/amarantus-bio...Rb7nz.dpuf
Do I have that right, they are increasing the authorized shares to TWO billion? wow, NOT being listed has its REALLY BIG advantages, you get to print money and not tell anyone when you do it until the end of the quarter.
I firmly believe that AMBS will never need to sell those shares, UNLESS OF COURSE, they want to keep going as a company. oh.
Someone noted that they would have to increase the float if they were going to get the LPC money, because of the tanked pps. I guess that was a correct assertion.
The finance part is not my forte, but I can read, doubling the float when it was just diluted down to undrinkable iced tea, is well, less drinkable.
AMBS the cult stock. How much of the company is owned by institutions? Interesting study in human behavior.
$$$$$$$$$$ AMBS $$$$$$$$$$
company has come a long way from this post in 2012,
(0)
(0)Scroll down for more posts ▼